ACIU logo

ACIU
AC Immune SA

3,854
Mkt Cap
$289.04M
Volume
144,553.00
52W High
$4.00
52W Low
$1.51
PE Ratio
-3.38
ACIU Fundamentals
Price
$2.84
Prev Close
$2.97
Open
$3.00
50D MA
$2.92
Beta
1.03
Avg. Volume
264,503.78
EPS (Annual)
-$0.8419
P/B
5.10
Rev/Employee
$35,264.75
$206.71
Loading...
Loading...
News
all
press releases
AC Immune (ACIU) to Release Quarterly Earnings on Wednesday
AC Immune (NASDAQ:ACIU) will be releasing its Q1 2026 earnings before the market opens on Wednesday, April 29. (View Earnings Report at...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know
AC Immune stock gains after expansion of its agreement with LLY, adding next-generation Tau Morphomer candidates and boosting long-term Alzheimer's strategy.
Zacks·17d ago
News Placeholder
Is AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year?
Here is how AC Immune (ACIU) and Assertio (ASRT) have performed compared to their sector so far this year.
Zacks·17d ago
News Placeholder
AC Immune Amends Morphomer Tau Agreement With Lilly
(RTTNews) - AC Immune SA (ACIU) said Tuesday it has agreed with Eli Lilly and Company (LLY) to amend their 2018 license and collaboration agreement to advance Tau aggregation inhibitor small molecules for the treatment of Alzheimer's disease and other neurodegenerative disorders...
Nasdaq News: Markets·19d ago
News Placeholder
AC Immune (NASDAQ:ACIU) Given Consensus Recommendation of "Hold" by Brokerages
Shares of AC Immune (NASDAQ:ACIU - Get Free Report) have received an average recommendation of "Hold" from the five ratings firms that are currently covering the firm, MarketBeat.com reports. One...
MarketBeat·19d ago
News Placeholder
AC Immune (NASDAQ:ACIU) Stock Price Passes Below Fifty Day Moving Average - Here's Why
AC Immune (NASDAQ:ACIU) Share Price Passes Below Fifty Day Moving Average - Time to Sell...
MarketBeat·26d ago
News Placeholder
AC Immune (ACIU) Upgraded to Buy: Here's Why
AC Immune (ACIU) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·1mo ago
News Placeholder
Is AC Immune (ACIU) Outperforming Other Medical Stocks This Year?
Here is how AC Immune (ACIU) and Anavex Life Sciences (AVXL) have performed compared to their sector so far this year.
Zacks·1mo ago
News Placeholder
FY2026 EPS Estimates for AC Immune Lifted by HC Wainwright
AC Immune (NASDAQ:ACIU - Free Report) - Analysts at HC Wainwright increased their FY2026 earnings per share (EPS) estimates for AC Immune in a research note issued on Monday, March 16th. HC...
MarketBeat·1mo ago
News Placeholder
Equities Analysts Issue Forecasts for AC Immune Q1 Earnings
AC Immune (NASDAQ:ACIU - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of AC Immune in a note issued to investors on Monday, March 16th. HC...
MarketBeat·1mo ago
<
1
2
...
>

Latest ACIU News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.